Tumor Necrosis Factor alpha inhibiting peptides and uses thereof

Details for Australian Patent Application No. 2009318779 (hide)

Owner Panacea Biotec Ltd

Inventors Jain, Rajesh; Vinayak, Virendra Kumar; Dubey, Shweta; Prasad, Sudhanand; Goel, Vijay; Jain, Rahul

Agent Watermark

Pub. Number AU-A-2009318779

PCT Pub. Number WO2010/058419

Priority 2622/DEL/2008 20.11.08 IN

Filing date 5 November 2009

Wipo publication date 27 May 2010

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/058419 Priority application(s): WO2010/058419

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009318783-Novel antimicrobials

2009318772-External stent